Reduce freezing of gait remotely
- Trial ID
- NCT06957405
- Official Title
- Effects of a Remote Mental and Physical Practice Intervention on Freezing of Gait in People With Parkinson's Disease: a Randomized Controlled Trial
- Goal
- Reduce freezing of gait remotely
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- University of Sao Paulo General Hospital
- Study Type
- INTERVENTIONAL
- Enrollment
- 50 participants
- Conditions
- Parkinson Disease, Freezing of Gait
- Interventions
- MPPG (Mental and Physical Practice Group), PPG (Physical Practice Group)
Plain-Language Summary
The goal is to reduce freezing of gait, those sudden moments when your feet feel glued to the floor, so walking becomes more fluid and less frightening. The intervention uses remote sessions that combine motor imagery, where you vividly rehearse walking and turning in your mind, with guided physical practice over video calls; the mental rehearsal is meant to strengthen the brain circuits that plan and trigger steps. These are non-drug therapies used alongside your usual dopaminergic medications, they do not replace levodopa but may help improve gait control when you are on medication. The trial is looking for about 50 people with idiopathic Parkinson's who report freezing of gait, can walk independently at home, use dopaminergic meds, have internet and a video device, and meet brief cognitive and motor imagery screening.
Locations
- University of Sao Paulo, São Paulo, São Paulo, Brazil
Frequently Asked Questions
- What is this trial testing?
- This trial is studying MPPG (Mental and Physical Practice Group). The goal is to reduce freezing of gait, those sudden moments when your feet feel glued to the floor, so walking becomes more fluid and less frightening. The intervention uses remote sessions that combine motor imagery, where you vividly rehearse walking and turning in your mind, with guided physical practice over video calls; the mental rehearsal is meant to strengthen the brain circuits that plan and trigger steps. These are non-drug therapies used alongside your usual dopaminergic medications, they do not replace levodopa but may help improve gait control when you are on medication. The trial is looking for about 50 people with idiopathic Parkinson's who report freezing of gait, can walk independently at home, use dopaminergic meds, have internet and a video device, and meet brief cognitive and motor imagery screening.
- Who can participate?
- Eligibility criteria vary. Check the full listing on ClinicalTrials.gov for detailed inclusion and exclusion criteria.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 6 months.